Hamps Bio Limited (BSE: 544312)
Health Care · Pharmaceuticals · IN
Rs25.50
+0.24% today · +21.4% 1Y
Hamps Bio Limited (BSE: 544312) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.30M.
Over the last twelve months the share price has gained 21.4%, trading between 13.36 and 26.58.
Tweenvest scores Hamps Bio Limited across four factors: quality 56/100, value 69/100, growth 55/100. Its strongest factor is value.
544312 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.30M
- Revenue (TTM)
- $903.80K
- P/E
- —
- EPS
- -0.85
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs26.58
- 52-week low
- Rs13.36
- Avg volume (3M)
- —
- Shares outstanding
- 8.71M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jaguar Health, Inc.NasdaqCM: JAGX | $2.49M | $4.56 | -4.80% |
| Société des Industries Pharmaceutiques de Tunisie - S.A.BVMT: SIPHA | $2.38M | DT3.97 | -12.56% |
| Pharmesis International Ltd.SGX: BFK | $2.36M | S$0.10 | — |
| Ishita Drugs and Industries LimitedBSE: 524400 | $2.35M | Rs76.00 | -0.26% |
| BioVaxys Technology Corp.CNSX: BIOV | $2.27M | CA$— | — |
| Cannabis Strategic VenturesOTCPK: NUGS | $1.97M | $0.00 | -30.99% |
| City View Green Holdings Inc.CNSX: CVGR | $1.90M | CA$0.04 | -12.50% |
| Colinz Laboratories LimitedBSE: 531210 | $1.90M | Rs73.03 | -0.64% |
Figures last refreshed Oct 11, 2026.